Anti-aging Therapeutics Market
完整報告名稱與涵蓋範圍
Anti-aging Therapeutics Market Size, Share & Trends Analysis Report By Type of Molecule (Biologics, Small Molecules), By Type of Aging (Cellular Aging, Immune Aging, Metabolic Aging, Others), By Mechanism of Action, By Region, And By Segment Forecasts, 2024-2031
報告摘要
Across the 2024 to 2031 projection horizon, the worldwide Anti-aging Therapeutics Market is set to register a CAGR of 17.62%.
Anti-aging Therapeutics encompasses challenges.
Several factors contribute to this trajectory, including heightened need next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region set to deliver the strongest growth trajectory through the forecast period, fueled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Anti-aging Therapeutics Market Snapshot
Chapter 4. Global Anti-aging Therapeutics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Molecule, Estimates & Trend Analysis
5.1. By Molecules, & Market Share, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Molecules:
5.2.1. Biologics
5.2.2. Small Molecules
Chapter 6. Market Segmentation 2: By Aging Types Estimates & Trend Analysis
6.1. By Aging Types & Market Share, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Aging Types:
6.2.1. Cellular Aging
6.2.2. Immune Aging
6.2.3. Metabolic Aging
6.2.4. Other Aging Types
Chapter 7. Market Segmentation 3: By Mechanism of Action Estimates & Trend Analysis
7.1. By Mechanism of Action & Market Share, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Mechanism of Action:
7.2.1. Senolytic
7.2.2. Cell Regeneration
7.2.3. mTOR inhibitor/Modulator
7.2.4. AMP-kinase/AMP Activator
7.2.5. Mitochondria Inhibitor/Modulator
7.2.6. other Mechanism of Action
Chapter 8. Anti-aging Therapeutics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Molecules, 2024-2031
8.1.2. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Aging Types, 2024-2031
8.1.3. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts By Mechanism of Action, 2024-2031
8.1.4. North America Anti-aging Therapeutics Market revenue (US$ Million) estimates and forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031
8.2.2. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031
8.2.3. Europe Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031
8.2.4. Europe Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, 2024-2031
8.3.2. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, 2024-2031
8.3.3. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, 2024-2031
8.3.4. Asia Pacific Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031
8.4.2. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031
8.4.3. Latin America Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031
8.4.4. Latin America Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Molecules, (US$ Million) 2024-2031
8.5.2. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Aging Types, (US$ Million) 2024-2031
8.5.3. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) By Mechanism of Action, (US$ Million) 2024-2031
8.5.4. Middle East & Africa Anti-aging Therapeutics Market revenue (US$ Million) by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. AgelessRx
9.2.2. ANOVA Institute for Regenerative Medicine
9.2.3. Betterhumans
9.2.4. BioAge Labs
9.2.5. BIOPHYTIS BSA
9.2.6. bioXcellerator
9.2.7. Cambrian Biopharma
9.2.8. CytoMed Therapeutics
9.2.9. Gero.ai
9.2.10. Rejuvenate Bio
9.2.11. Rejenevie Therapeutics
9.2.12. UT Health San Antonio
9.2.13. MyMD Pharmaceuticals
9.2.14. Intervene Immune, Inc.
9.2.15. CohBar, Inc.
9.2.16. Alkahest
9.2.17. Athersys Inc
9.2.18. BHB Therapeutics
9.2.19. Biosplice
9.2.20. Cyclo Therapeutics
9.2.21. Denali Therapeutics
9.2.22. Elysium Health
9.2.23. Genome Protection
9.2.24. GenSight Biologics
9.2.25. Intervene Immune
9.2.26. Khondrian
9.2.27. Longeveron
9.2.28. LyGenesis
9.2.29. Mesoblast
9.2.30. Minovia Therapeutics
9.2.31. Mitobridge
9.2.32. Navitor Pharmaceuticals
9.2.33. NeuroTrack
9.2.34. Nuchido
9.2.35. NuSirt
9.2.36. OneSkin Technologies
9.2.37. PharmatrophiX
9.2.38. Proteostasis Therapeutics
9.2.39. Retrotope
9.2.40. Stealth Biotherapeutics
9.2.41. TA Sciences
9.2.42. Unity Biotechnology
9.2.43. Younger Phenotype
9.2.44. Other Prominent Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們